A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells-known as ...

“Heart age, or PREVENT age, may be particularly useful for patients and clinicians and be more effective in preventing heart ...

Heart attacks increase heart failure risk. Dr. Teuteberg believes cardiac attacks damage the heart, making it pump less ...

Pregabalin was associated with an increased risk for heart failure relative to another widely used gabapentinoid, based on an ...

A recent study by researchers at UVA Health and Virginia Commonwealth University has found that a heart failure drug may ...

Patients receive individualized plans aimed at helping them overcome structural barriers that often impede successful ...

Pope Leo XVI met with pilgrims from Egypt on Saturday, after learning one of their members died on her way to Rome for the ...

How Was It Studied to Treat Heart Failure, and What Benefits Were Seen? Early studies showed that in people with type 2 diabetes who have heart disease or risk factors for heart disease, Farxiga ...

Heart failure not only leads to issues in the heart but other organs in the body as well. This can lead to many different symptoms developing, which may need multiple medicines to manage.

According to the National Heart, Lung, and Blood Institute, about 5.7 million people in the U.S. have heart failure, and it can affect both children and adults.